OKYO Pharma Limited fell 13.0% on Monday, November 16, 2026, on 3,710,000 shares, 26 times its average daily volume. No headline about OKYO came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
OKYO Pharma Limited (OKYO:NASDAQ) closed at $1.07 on November 20, 2026, down 7.76% on the day. The stock trades 66.6% below its 52-week high of $3.20 and 7.0% above its 52-week low of $1.00. Over the past year, it lost 48.6%. OKYO Pharma Limited is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, OKYO closed higher on 103 days (41%). Its best day was January 9, 2026 (+18.97%) and its worst was February 13, 2026 (-19.35%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 3 times.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Find more stocks like OKYO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.